Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
ZyVersa Therapeutics, Inc. (ZVSA) had Weighted-Average Shares Outstanding (Basic) of 5.96M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-0.68M |
|
-- |
|
-- |
|
$0.55M |
|
$-0.55M |
|
$-0.11M |
|
$-0.68M |
|
$-0.68M |
|
$-0.68M |
|
$-0.68M |
|
$-0.68M |
|
$-0.68M |
|
$-0.55M |
|
$-0.55M |
|
|
Weighted-Average Shares Outstanding (Basic) |
5.96M |
5.96M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$0.35M |
|
-- |
|
-- |
|
$0.35M |
|
$12.73M |
|
-- |
|
-- |
|
$12.73M |
|
$-12.39M |
|
$-12.39M |
|
$-12.39M |
|
8.10M |
|
| Cash Flow Statement Financials | |
$-5.11M |
|
-- |
|
$3.69M |
|
$1.53M |
|
$0.10M |
|
$-1.43M |
|
$0.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
5.48% |
|
5.48% |
|
-195.05% |
|
5.48% |
|
$-1.53 |
|
$-0.86 |
|
$-0.86 |
|